Home » Managing Illnesses » A Phase III Clinical Trial (FLORA-5) for Advanced Ovarian Cancer

A Phase III Clinical Trial (FLORA-5) for Advanced Ovarian Cancer


Ovarian cancer is categorized as advanced once the cancer has spread away from its site of origin in the pelvis. OncoQuest is grateful to all the listed investigators in Canada for participating in FLORA-5, which begins enrolling on May 1, 2021. Many clinical trials are currently taking place to look at new ways to prevent, find, and treat ovarian cancer. Talk to your health care team to find out if you‘re a candidate for clinical trials.

Principle Investigator
Dr. Mélanie Arbour-Levert⠀⠀⠀⠀⠀⠀⠀⠀⠀Cité de la Santé de Laval
Laval, QC
Dr. Allan Covens Toronto Sunnybrook Hospital
Toronto, ON
Dr. Lucy Gilbert McGill University Health Centre Glen Site/Royal Victoria Hospital
Montreal, QC
Dr. Diane ProvencherCHUM Centre de Recherche
Montreal, QC
Dr. Paul BessetteCHUS – Hôpital Fleurimont
Sherbrooke, QC
Dr. Katharina Kieser Queen Elizabeth II Health Sciences Centre
Halifax, NS

Next article